SynCardia Systems, a developer and manufacturer of temporary implantable artificial hearts, withdrew its plans for an initial public offering on Tuesday.
The Tucson, AZ-based company was founded in 2001 and booked $18 million in sales for the 12 months ended June 30, 2015. It had planned to list on the Nasdaq under the symbol TAHT. Roth Capital was set to be the sole bookrunner on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
